On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B.

The Journal of Biological Chemistry
D V SakharovD C Rijken

Abstract

The precursor of plasma carboxypeptidase B (pCPB) also known as thrombin-activable fibrinolysis inhibitor can be converted by thrombin to an active enzyme capable of eliminating C-terminal Lys- and Arg-residues from proteins. The activation is about 1000-fold more efficient in the presence of thrombomodulin (TM). We investigated the antifibrinolytic potency of maximally activated pCPB in plasma and explored the antifibrinolytic mechanism of pCPB. During clotting of plasma in the presence of 3.3 NIH units/ml thrombin and 1 microg/ml soluble TM, more than 80% pro-pCPB was converted into the active form causing an increase of plasma carboxypeptidase activity from 100 units/liter (constitutive activity ascribed to plasma carboxypeptidase N) to 430 units/liter as measured with furoylacroleyl-alanyl-arginine substrate. Under these conditions, lysis of a plasma clot induced by a range of tissue-type plasminogen activator (t-PA) concentrations (0.2-2 microg/ml) was retarded more than 4-fold. A considerable retardation of fibrinolysis was observed upon addition of as little as 12 ng/ml soluble TM, a concentration comparable with physiological concentrations of soluble TM in human plasma. The presence of Ca2+ appeared to be a critical re...Continue Reading

References

Apr 6, 1978·Nature·B Wiman, D Collen
Apr 1, 1992·Journal of the American College of Cardiology·P TanswellE Seifried
Apr 23, 1990·Biochimica Et Biophysica Acta·D HendriksM van Sande
May 1, 1989·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·D HendriksM P Lommaert
May 15, 1985·European Journal of Biochemistry·B NorrmanM Rånby
Nov 1, 1995·The Journal of Clinical Investigation·A RedlitzE F Plow
Oct 1, 1995·Circulation·D V Sakharov, D C Rijken
Jun 16, 1995·The Journal of Biological Chemistry·L BajzarM E Nesheim
Apr 1, 1993·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·N J de FouwR M Bertina
Sep 20, 1996·The Journal of Biological Chemistry·L BajzarP B Tracy

❮ Previous
Next ❯

Citations

Nov 10, 2011·Die Naturwissenschaften·Jan-Peter Hildebrandt, Sarah Lemke
Feb 25, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·K A SchattemanD F Hendriks
Sep 25, 2001·Thrombosis Research·D C Rijken, D V Sakharov
Feb 20, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·J AntovicM Blombäck
Jan 29, 2000·The European Journal of Neuroscience·A MatsumotoR Matsumoto
Jul 11, 2009·The Journal of Biological Chemistry·Nicolas S PetreraJeffrey I Weitz
Feb 7, 2008·The Journal of Biological Chemistry·Jonathan H FoleyMichael E Nesheim
Aug 29, 2000·Current Opinion in Hematology·B N Bouma, J C Meijers
May 1, 2004·Critical Care Medicine·Laszlo BajzarJohn B Walker
Aug 12, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Shi-Shan MaoJacquelynn J Cook
May 3, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Elisabeth RoothJoven Antovic
Jun 22, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Bashir A LwaleedAlan J Cooper
Jan 10, 2002·The Journal of Clinical Investigation·Mariko NagashimaJohn Morser
Nov 6, 2002·The Journal of Clinical Investigation·Carmen M SwaisgoodEdward F Plow
Nov 5, 2003·CNS Drugs·Geoffrey A DonnanStephen M Davis
Jan 1, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Joanna DubisWojciech Witkiewicz
Nov 6, 2013·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Shenggang WangGuangjun Suo
Mar 22, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A E ZuurbierD Roos
Jul 2, 2005·Expert Opinion on Emerging Drugs·O IqbalJ Fareed
Jun 10, 2005·FEBS Letters·Colin Longstaff, Craig Thelwell
Sep 30, 2006·Annals of Medicine·Bonno N Bouma, Laurent O Mosnier
Sep 5, 2015·Journal of Thrombosis and Haemostasis : JTH·D LeenaertsD Hendriks
Feb 7, 2001·Chest·J I Weitz, J Hirsh
Nov 20, 1998·Chest·J I Weitz, J Hirsh
Jan 20, 2009·Clinics in Liver Disease·Domenico FerroFrancesco Violi
Mar 2, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·María Asunción Esteve-PastorFrancisco Marín
Oct 1, 2005·Journal of Thrombosis and Haemostasis : JTH·N L M CrudenD E Newby

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.